Hiroshi Suzuki
Impact in
- Oncology top 0.1%
- Drug Transport and Resistance Mechanisms
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
Papers in
- Oncology 192
- Drug Transport and Resistance Mechanisms 138
- Pharmacology 41
- Pharmacogenetics and Drug Metabolism 26
- Antibiotics Pharmacokinetics and Efficacy 24
- Co-authors
- Yuichi SugiyamaKohei MiyazonoTappei TakadaKoichi SugimotoTatsuhiko KodamaTomoko HirohashiKousei ItoHironori Matsuyama
- Journals
- Journal of Pharmacology and Experimental Therapeutics (23 papers)Pharmaceutical Research (19 papers)Journal of Biological Chemistry (15 papers)Drug Metabolism and Disposition (15 papers)American Journal of Physiology-Gastrointestinal and Liver Physiology (11 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hiroshi Suzuki
519 papers receiving 25.2k citations
Hit Papers
Peers
Comparison fields: 5 of 190
- Oncology 9.2k
- Pharmacology 2.3k
- Cancer Research 3.6k
- Pediatrics, Perinatology and Child Health 3.3k
- Molecular Biology 10.7k
Countries citing papers authored by Hiroshi Suzuki
This map shows the geographic impact of Hiroshi Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Suzuki more than expected).
Fields of papers citing papers by Hiroshi Suzuki
This network shows the impact of papers produced by Hiroshi Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Suzuki. The network helps show where Hiroshi Suzuki may publish in the future.
Co-authors
The 25 scholars most cited alongside Hiroshi Suzuki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 11 | |
| 3 | 2023 | 17 | |
| 4 | 2023 | 3 | |
| 5 | 2023 | 2 | |
| 6 | 2021 | 12 | |
| 7 | 2020 | 17 | |
| 8 | 2018 | 18 | |
| 9 | 2017 | 19 | |
| 10 | 2014 | 77 | |
| 11 | 2014 | 21 | |
| 12 | 2010 | 2 | |
| 13 | 2009 | 244 | |
| 14 | 2008 | 16 | |
| 15 | TRANSIENT EXPRESSION OF A GREEN FLUORESCENT PROTEIN GENE IN BABESIA BOVIS | 2003 | 1 |
| 16 | Transport of sulfated conjugates by human breast cancer resistance protein (BCRP/ABCG2) | 2002 | 1 |
| 17 | 2000 | 264 | |
| 18 | 2000 | 203 | |
| 19 | 1989 | 30 | |
| 20 | 1988 | 6 |
About Hiroshi Suzuki
Hiroshi Suzuki is a scholar working on Oncology, Pharmacology, Cancer Research, Pediatrics, Perinatology and Child Health and Nephrology, having authored 533 papers that have together received 25.8k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (138 papers), Pharmacological Effects and Toxicity Studies (60 papers), MicroRNA in disease regulation (29 papers), Cholesterol and Lipid Metabolism (28 papers), Pharmacogenetics and Drug Metabolism (26 papers), Antibiotics Pharmacokinetics and Efficacy (24 papers), Pediatric Hepatobiliary Diseases and Treatments (21 papers) and RNA modifications and cancer (20 papers). The work is most often cited by research in Oncology (9.2k citations), Pharmacology (2.3k citations), Cancer Research (3.6k citations), Pediatrics, Perinatology and Child Health (3.3k citations) and Molecular Biology (10.7k citations). Hiroshi Suzuki has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Yuichi Sugiyama, Kohei Miyazono, Tappei Takada, Koichi Sugimoto, Tatsuhiko Kodama, Tomoko Hirohashi, Kousei Ito, Hironori Matsuyama, Kaoru Yamagata and Takashi Iwamoto. Their work appears in journals such as Journal of Pharmacology and Experimental Therapeutics, Pharmaceutical Research, Journal of Biological Chemistry, Drug Metabolism and Disposition and American Journal of Physiology-Gastrointestinal and Liver Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.